JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-29
DOI
10.3389/fphar.2022.821344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors
- (2021) Joline Roze et al. Cancers
- Helicobacter pylori Subdues Cytokine Signaling to Alter Mucosal Inflammation via Hypermethylation of Suppressor of Cytokine Signaling 1 Gene During Gastric Carcinogenesis
- (2021) Iqra Jan et al. Frontiers in Oncology
- Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
- (2021) Maryam Aftabizadeh et al. JCI Insight
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
- (2021) Md. Abdul Aziz et al. LIFE SCIENCES
- The translational values of TRIM family in pan-cancers: from functions and mechanisms to clinics
- (2021) Guo Zhao et al. PHARMACOLOGY & THERAPEUTICS
- JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance
- (2021) Hatem E Sabaawy et al. CARCINOGENESIS
- The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling
- (2021) Jessica Fiebelkow et al. Cell Communication and Signaling
- Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells
- (2021) Merve Erkisa et al. CURRENT MEDICINAL CHEMISTRY
- The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
- (2021) Chiara Baldini et al. EUROPEAN HEART JOURNAL
- Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the JAK2/STAT3 signaling pathway
- (2021) Zhenxian Jia et al. ONCOLOGY REPORTS
- Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer
- (2021) Bilal Rah et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of MiR-210 on the Chemosensitivity of Breast Cancer by Regulating JAK-STAT Signaling Pathway
- (2021) Zeyu Xing et al. Biomed Research International
- Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
- (2021) Nikita Aggarwal et al. Frontiers in Pharmacology
- NF-κB and Human Cancer: What Have We Learned over the Past 35 Years?
- (2021) Thomas D. Gilmore Biomedicines
- The role of JAK/STAT signaling pathway and its inhibitors in diseases
- (2020) Ping Xin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis
- (2020) Hongyan Qi et al. Oncogenesis
- microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK/STAT3 and NF-κB signaling pathways
- (2020) Sajjad Masoumi-Dehghi et al. Journal of Cell Communication and Signaling
- Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise
- (2020) William J. Kraemer et al. Frontiers in Endocrinology
- Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary Review
- (2020) Asaf Maoz et al. Cancers
- The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology
- (2020) Natalie A. Sims EXPERIMENTAL AND MOLECULAR MEDICINE
- Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
- (2020) Matthias Pinter et al. GUT
- JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)
- (2020) Kazuya Shimoda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
- (2020) Sankhadip Bose et al. Cells
- STAT3 transcription factor as target for anti-cancer therapy
- (2020) Aliaa M. Mohassab et al. Pharmacological Reports
- Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
- (2020) Ethan L. Morgan et al. Viruses-Basel
- Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer
- (2020) Wei Wen et al. Cancers
- Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
- (2020) Adriana Gutiérrez-Hoya et al. Cells
- The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy
- (2020) Andreea D. Lazăr et al. Cancers
- Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
- (2019) Chin-Yap Loh et al. Frontiers in Oncology
- Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation
- (2019) Yubin Ji et al. OncoTargets and Therapy
- Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1α and Increased Levels of Reactive Oxygen Species
- (2019) Ke He et al. Oxidative Medicine and Cellular Longevity
- Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer
- (2019) Zhengwu Cheng et al. ONCOLOGY REPORTS
- Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology
- (2019) Carlota Recio et al. ONCOGENE
- Curcumin: New Insights into an Ancient Ingredient against Cancer
- (2019) Ella Willenbacher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical development of targeted and immune based anti-cancer therapies
- (2019) N. A. Seebacher et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
- (2019) Gulcin Tezcan et al. Frontiers in Pharmacology
- Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways
- (2019) Zhengyang Lu et al. Molecular Medicine Reports
- Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
- (2019) Shoumin Zhu et al. ONCOGENE
- Fibroblast Growth Factors: A Controlling Mechanism of Skin Aging
- (2019) Rousilândia de Araújo et al. SKIN PHARMACOLOGY AND PHYSIOLOGY
- IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
- (2019) Moritz F. Eissmann et al. Nature Communications
- JAK/STAT signaling in insect innate immunity
- (2019) In Seok Bang ENTOMOLOGICAL RESEARCH
- Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer
- (2019) Felicia Paulraj et al. Biomolecules
- LINC00346 promotes hepatocellular carcinoma progression via activating the JAK‐STAT3 signaling pathway
- (2019) Yun‐Zhi Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
- (2019) Yaojie Fu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
- (2019) Alqahtani et al. Medicina-Lithuania
- Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
- (2019) Khan et al. Cells
- Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
- (2019) Alessia Alunno et al. Cells
- Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
- (2019) Qiuyao Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- Repurposing of drugs as STAT3 inhibitors for cancer therapy
- (2019) Pathum S. Thilakasiri et al. SEMINARS IN CANCER BIOLOGY
- Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders
- (2019) Geoffrey Shouse et al. Current Hematologic Malignancy Reports
- Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
- (2019) Bridget P. Keenan et al. Journal for ImmunoTherapy of Cancer
- A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
- (2019) Braicu et al. Cancers
- STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
- (2019) Carol Lee et al. Cancers
- Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
- (2019) Marco Tucci et al. Frontiers in Oncology
- Precision medicine in gastric cancer
- (2019) Patrizia Bonelli et al. World Journal of Gastrointestinal Oncology
- Epigenetic Regulation of T Cell Memory: Recalling Therapeutic Implications
- (2019) David F. Tough et al. TRENDS IN IMMUNOLOGY
- Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
- (2019) Chin-Jui Wu et al. Cancers
- Prognostic roles of signal transducers activators of transcription family in human breast cancer
- (2018) Shuntao Wang et al. BIOSCIENCE REPORTS
- Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer
- (2018) Kriti Ray et al. CYTOKINE & GROWTH FACTOR REVIEWS
- STAT3: a multifaceted oncoprotein
- (2018) Aleks C. Guanizo et al. GROWTH FACTORS
- Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer
- (2018) Yuzo Maeda et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular mechanisms of drug resistance in ovarian cancer
- (2018) Leyla Norouzi-Barough et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial
- (2018) Min-Ke He et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
- (2018) Bettina Wingelhofer et al. LEUKEMIA
- Mechanisms of receptor tyrosine kinase activation in cancer
- (2018) Zhenfang Du et al. Molecular Cancer
- Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
- (2018) Jenny D. Beebe et al. PHARMACOLOGY & THERAPEUTICS
- RAS-mediated oncogenic signaling pathways in human malignancies
- (2018) Abdul Q. Khan et al. SEMINARS IN CANCER BIOLOGY
- JAK/STAT – Emerging Players in Metabolism
- (2018) David W. Dodington et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Biomarkers of gastric cancer: Current topics and future perspective
- (2018) Tasuku Matsuoka et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis
- (2018) Do-Hyun Kim et al. Nature Communications
- Gastric cancer: epidemiology, prevention, classification, and treatment
- (2018) Robert Sitarz et al. Cancer Management and Research
- Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase
- (2018) Stevan R. Hubbard Frontiers in Endocrinology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis
- (2018) Wei Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis
- (2018) Atsushi Hiraoka et al. HEPATOLOGY RESEARCH
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
- (2018) Meng-Yu Wu et al. Journal of Clinical Medicine
- “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
- (2018) Emira Bousoik et al. Frontiers in Oncology
- The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma
- (2018) Ying Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A survey of inter-individual variation in DNA methylation identifies environmentally responsive co-regulated networks of epigenetic variation in the human genome
- (2018) Paras Garg et al. PLoS Genetics
- Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
- (2018) Matilda Lee et al. Redox Biology
- Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion
- (2018) Ken Tawara et al. Translational Oncology
- Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
- (2017) Tatjana Lazarević et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Investigational Janus kinase inhibitors in development for myelofibrosis
- (2017) Prithviraj Bose et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The roles of CSFs on the functional polarization of tumor-associated macrophages
- (2017) Pascale Jeannin et al. FEBS Journal
- An updated review on molecular mechanisms underlying the anticancer effects of capsaicin
- (2017) Seok-Cheol Cho et al. FOOD SCIENCE AND BIOTECHNOLOGY
- Modulation of antitumor immunity with histone deacetylase inhibitors
- (2017) Tyler R McCaw et al. Immunotherapy
- Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice
- (2017) Takahito Sugase et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinoma
- (2017) Jae Ryung Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015
- (2017) Chante Karimkhani et al. LANCET INFECTIOUS DISEASES
- Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
- (2017) Bernd Groner et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
- (2017) Galina Khemlina et al. Molecular Cancer
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- Epigenetics in cancer: Fundamentals and Beyond
- (2017) Subhankar Biswas et al. PHARMACOLOGY & THERAPEUTICS
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
- (2017) Fernando Janczur Velloso et al. OncoTargets and Therapy
- Responses to Cytokines and Interferons that Depend upon JAKs and STATs
- (2017) George R. Stark et al. Cold Spring Harbor Perspectives in Biology
- Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
- (2017) Eirini Pectasides et al. Cancer Discovery
- Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients
- (2017) Shu Zhang et al. Oncotarget
- Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis
- (2017) De-Dong Cao et al. Oncotarget
- STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells
- (2017) Xing-Hua Liao et al. Oncotarget
- MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain
- (2017) Dong Ju Son et al. Theranostics
- The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer
- (2017) Ashok Shiani et al. Cancer Control
- Medical management of gastric cancer: a 2017 update
- (2017) Nikolaos Charalampakis et al. Cancer Medicine
- Gastric adenocarcinoma
- (2017) Jaffer A. Ajani et al. Nature Reviews Disease Primers
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- Molecular classification of gastric cancer
- (2016) N.-Y. Chia et al. ANNALS OF ONCOLOGY
- Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
- (2016) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer
- (2016) Adam C. ElNaggar et al. CANCER BIOLOGY & THERAPY
- JAK-STAT signaling in cancer: From cytokines to non-coding genome
- (2016) Jan Pencik et al. CYTOKINE
- Targeted blockade of JAK/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells
- (2016) Yuan-Jing Gu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- STAT5 in Cancer and Immunity
- (2016) Aradhana Rani et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer
- (2016) Z Zhou et al. ONCOGENE
- Oral cancer: Deregulated molecular events and their use as biomarkers
- (2016) Nicoleta Sinevici et al. ORAL ONCOLOGY
- Targeting transcription factor STAT3 for cancer prevention and therapy
- (2016) Edna Zhi Pei Chai et al. PHARMACOLOGY & THERAPEUTICS
- The Structural Basis for Class II Cytokine Receptor Recognition by JAK1
- (2016) Ryan Ferrao et al. STRUCTURE
- Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
- (2016) Kunxin Luo Cold Spring Harbor Perspectives in Biology
- JNK1/2 expression and modulation of STAT3 signaling in oral cancer
- (2016) IOANNIS GKOUVERIS et al. Oncology Letters
- Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis
- (2016) Alexander V. Ivanov et al. Oncotarget
- Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer
- (2016) Chung-Min Yeh et al. Scientific Reports
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- JAK2 activation by growth hormone and other cytokines
- (2015) Michael J. Waters et al. BIOCHEMICAL JOURNAL
- Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
- (2015) Gaurav Joshi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- A STAT inhibitor patent review: progress since 2011
- (2015) Ping-Shan Lai et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
- (2015) Shinya Ohashi et al. GASTROENTEROLOGY
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- The JAK/STAT signaling cascade in gastric carcinoma (Review)
- (2015) PUJA KHANNA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Non-canonical Stat3 signaling in cancer
- (2015) Jaya Srivastava et al. MOLECULAR CARCINOGENESIS
- Targeting JAK kinase in solid tumors: emerging opportunities and challenges
- (2015) M Buchert et al. ONCOGENE
- Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer
- (2015) Shrikant Balasaheb Mali ORAL ONCOLOGY
- A historical overview of protein kinases and their targeted small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Therapeutic targeting of replicative immortality
- (2015) Paul Yaswen et al. SEMINARS IN CANCER BIOLOGY
- Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
- (2015) Elisabetta Rovida et al. SEMINARS IN CANCER BIOLOGY
- Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
- (2015) Murugan Kalimutho et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma
- (2015) Jian-Jun Gao WORLD JOURNAL OF GASTROENTEROLOGY
- Biological and therapeutic activities, and anticancer properties of curcumin
- (2015) DONATELLA PERRONE et al. Experimental and Therapeutic Medicine
- A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
- (2015) Hong Zhao et al. Oncotarget
- Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
- (2015) Roberto Bellucci et al. OncoImmunology
- Mechanisms of resistance to EGFR tyrosine kinase inhibitors
- (2015) Lihua Huang et al. Acta Pharmaceutica Sinica B
- STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
- (2015) Valeria Poli et al. Frontiers in Oncology
- Cancer stem cell plasticity and tumor hierarchy
- (2015) Marina Carla Cabrera World Journal of Stem Cells
- Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
- (2015) Malgorzata Szelag et al. PLoS One
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma
- (2014) Mahmoud A. Mansour et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Astaxanthin Inhibits JAK/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer
- (2014) J. Kowshik et al. PLoS One
- Synergistic effects of curcumin and bevacizumab on cell signaling pathways in hepatocellular carcinoma
- (2014) JIAN-ZHI GAO et al. Oncology Letters
- Targeting STAT3 in gastric cancer
- (2012) Andrew S Giraud et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
- (2011) Siyuan Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
- (2009) Rebecca J. Leeman-Neill et al. CARCINOGENESIS
- Understanding Signaling Cascades in Melanoma
- (2008) Pablo Lopez-Bergami et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started